Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Profit From the Correction: Cisco Stock Is a Strong Buy

By Ian Bezek, InvestorPlace Contributor

Cisco is going through a soft patch right now. That temporary weakness has created a great opportunity for long-term investors.

7 Stocks to Sell as We Enter a Bear Market

By Ian Bezek, InvestorPlace Contributor

The stock market officially entered bear market territory Wednesday night. Here are seven stocks to sell before they plunge even more.

Gilead Sciences Stock: Still Cheap but Don’t Count On a Coronavirus Rally

By Ian Bezek, InvestorPlace Contributor

Gilead Sciences has scored a lot of attention with its drug that may treat coronavirus. That doesn't necessarily make GILD stock a buy yet, though.

Don’t Blast Off With Virgin Galactic Stock Yet

By Ian Bezek, InvestorPlace Contributor

Space travel sounds amazing. But investors should take a second and consider what SPCE stock truly is before buying into the story.

Buy the Dip in These 7 Online Advertising Stocks Now

By Ian Bezek, InvestorPlace Contributor

Online advertising stocks have sold off sharply in recent weeks on coronavirus fears. Here are 7 to put on your watch list.

The Road Ahead for Nio Remains Bumpy

By Ian Bezek, InvestorPlace Contributor

Nio has staved off insolvency for the time being. But it will take a lot more than that to justify any rebound in Nio's sagging share price.

The Real Reason to Buy MMM Stock Now (Hint: It’s Not the Coronavirus)

By Ian Bezek, InvestorPlace Contributor

With 3M stock recently hitting its lowest level in five years, it's time to stock up. But don't get too excited about the face mask hype.

JD Is A Great Company Stuck In A Terrible Situation

By Ian Bezek, InvestorPlace Contributor

JD remains a wonderful e-commerce company, but current events in China threaten a steep correction for JD stock this quarter.

Acasti Pharma Is a Risky Play After Releasing Disappointing Data

By Ian Bezek, InvestorPlace Contributor

Acasti Pharma stock plunged after the company reported negative trial results. The company's road ahead is filled with risks.

Don’t Get Too Excited Over the Near-Future Prospects for CGC Stock

By Ian Bezek, InvestorPlace Contributor

Canopy took the first step toward a turnaround, and the new CEO is facing up to the company's challenges. But much more remains to be done.

Load More